scholarly journals Capsule Endoscopy in Patients with Cardiac Pacemakers and Implantable Cardioverter Defibrillators: (Re)evaluation of the Current State in Germany, Austria, and Switzerland 2010

2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Dirk Bandorski ◽  
Ralf Jakobs ◽  
Martin Brück ◽  
Reinhard Hoeltgen ◽  
Marcus Wieczorek ◽  
...  
Keyword(s):  
Capsule Endoscopy ◽  
Cardiac Pacemaker ◽  
Implantable Cardioverter Defibrillators ◽  
Cardiac Pacemakers ◽  
Current State ◽  
Before And After ◽  
Type Of Institution ◽  
Cardioverter Defibrillators ◽  
Repeated Evaluation

Background and Aims. The study was a repeated evaluation of the experience of capsule endoscopy (CE) in patients with cardiac pacemaker or implantable cardioverter defibrillator (ICD).Patients and Methods. A standardized questionnaire was sent by the manufactors Given Imaging and Olympus to all centers in Germany, Austria, and Switzerland providing capsule endoscopy service. The questionnaire covers the number of examined patients, monitoring during CE, check of the electric implants before and after CE, occurrence of arrhythmia, quality of CE video, complications, indication of CE, and type of institution.Results. Overall 580 questionnaires were sent to the users. 26/5% (Germany/Austria + Switzerland) of the questionnaires were sent back anonymously to the authors. 114 centers (82 hospitals, 11 surgeries, 21 without specification) replied. In 58 centers (51%), patients with cardiac pacemaker (n=300) and ICDs (n=80) underwent uneventful capsule endoscopy. The predominant indication (patients with CP 97%, patients with ICD 100%) was mid gastrointestinal bleeding.Conclusion. The results of our inquiry show that in spite of formal contraindication CE is increasingly applied in bleeding patients with cardiac pacemakers/ICDs and seems to be safe even in a large cohort.

Deactivating Cardiac Pacemakers and Implantable Cardioverter Defibrillators in Terminally Ill Patients

2009 ◽  
Vol 18 (3) ◽  
pp. 236-240 ◽  
Author(s):  
JUAN PABLO BECA ◽  
EDUARDO ROSSELOT ◽  
RENÉ ASENJO ◽  
VERÓNICA ANGUITA ◽  
RAFAEL QUEVEDO
Keyword(s):  
Gastric Cancer ◽  
Cardiac Arrhythmia ◽  
Hepatic Metastasis ◽  
General Condition ◽  
Terminally Ill ◽  
Cardiac Pacemaker ◽  
Implantable Cardioverter Defibrillators ◽  
Cardiac Pacemakers ◽  
The Family ◽  
Cardioverter Defibrillators

A 68-year-old patient who suffered from gastric cancer diagnosed 8 months earlier presented with multiple peritoneal and hepatic metastasis, despite several rounds of chemo- and radiotherapy. After admission to hospital, his general condition quickly became severely compromised. He was nearly emaciated, despite being on partial parenteral feeding. Four years earlier, due to a cardiac arrhythmia that was refractory to medication, the patient had a cardiac pacemaker (CPM) implanted, regulated to go off at frequencies of below 70 beats per minute. Given the patient's terminal situation, the team started developing some doubts about the pacemaker's effects during his dying process. The patient had mentioned his intention to donate his pacemaker after his death, but had not asked for its deactivation. The specialists were not sure about the effect of the pacemaker in unnecessarily prolonging the patient's final hour. Nevertheless, they opposed deactivation, which they considered ethically uncertain. The family, who had been initially for the deactivation, decided against it. The patient's condition was progressively deteriorating, as he was falling into a state of sopor and, later, into a coma.

scholarly journals Capsule Endoscopy in Patients with Cardiac Pacemakers, Implantable Cardioverter Defibrillators, and Left Heart Devices: A Review of the Current Literature

2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Dirk Bandorski ◽  
Martin Keuchel ◽  
Martin Brück ◽  
Reinhard Hoeltgen ◽  
Marcus Wieczorek ◽  
...  
Keyword(s):  
Capsule Endoscopy ◽  
In Vivo Studies ◽  
Implantable Cardioverter Defibrillators ◽  
Left Heart ◽  
Cardiac Pacemakers ◽  
Technical Data ◽  
Cardiac Devices ◽  
Cardioverter Defibrillators

Background and Study Aims. Capsule endoscopy is an established tool for investigation of the small intestine. Because of limited clinical experience in patients with cardiac devices, the Food and Drug Administration and the manufacturer recommended not to use capsule endoscopy in these patients. The vast majority of investigations did not reveal any interference between capsule endoscopy and cardiac devices. Methods. Studies investigating interference between CE and cardiac devices were analysed. For the review we considered studies published in English or German and indexed in Medline, as well as highly relevant abstracts. Results. In vitro and in vivo studies mainly revealed no interference between capsule endoscopy and cardiac devices. Technical data of capsule endoscopy (Given Imaging) reveal that interference with cardiac pacemakers and implantable cardioverter defibrillator is impossible. Telemetry can interfere with CE video. Conclusion. The clinical use of capsule endoscopy (Given Imaging) is unproblematic in patients with cardiac pacemakers.

Predictors of Quality of Life in Patients With Implantable Cardioverter Defibrillators

2005 ◽  
Vol 46 (5) ◽  
pp. 451-457 ◽  
Author(s):  
Samuel F. Sears ◽  
Tara Saia Lewis ◽  
Emily A. Kuhl ◽  
Jamie B. Conti
Keyword(s):  
Quality Of Life ◽  
Implantable Cardioverter Defibrillators ◽  
Cardioverter Defibrillators

Health-Related Quality of Life Consequences of Implantable Cardioverter Defibrillators

Medical Care ◽  
2007 ◽  
Vol 45 (5) ◽  
pp. 377-385 ◽  
Author(s):  
Katia Noyes ◽  
Ethan Corona ◽  
Jack Zwanziger ◽  
W Jackson Hall ◽  
Hongwei Zhao ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Implantable Cardioverter Defibrillators ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related ◽  
Cardioverter Defibrillators

Psychosocial Issues of Patients With Implantable Cardioverter Defibrillators

2005 ◽  
Vol 14 (4) ◽  
pp. 294-303 ◽  
Author(s):  
Sandra B. Dunbar
Keyword(s):  
Quality Of Life ◽  
High Risk ◽  
Standard Therapy ◽  
Ventricular Arrhythmias ◽  
Evidence Based ◽  
Psychosocial Issues ◽  
Implantable Cardioverter Defibrillators ◽  
Life Threatening ◽  
Cardioverter Defibrillators

Use of implantable cardioverter defibrillators has become standard therapy for patients at high risk for life-threatening ventricular arrhythmias. Although acceptance of the device is generally high among patients and their families, quality of life and psychosocial issues associated with use of the defibrillators deserve greater attention to improve outcomes. Psychosocial issues, their ramifications, and theory-and evidence-based approaches to improving outcomes are described.

Sign in / Sign up

Export Citation Format

Share Document